With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
In this video, Karen Ignagni, President and Chief Executive Officer, America's Health Insurance Plans (AHIP), addresses the importance of joining The American Journal of Managed Care’s Strategic Alliance Partner Program.
Charles Kennedy, MD, MBA, CEO, Accountable Care Solutions, Aetna Inc., says that part of an Accountable Care Organization's (ACOs) objective is changing how care is delivered.
The underlying mechanisms of cancer immunotherapy can be broken down into various categories, including the manipulation of chemical (ie, cytokine) signaling, the use of antibodies and other cell-based therapies, and the development of vaccines, which is considered the “Holy Grail” of cancer immunotherapy.
Lauren Meyer, PharmD; Cassandra Ford, PharmD; Kristen Harrison, MPH; Nirmal K. Ghuman, PharmD, MPH; Olga S. Matlin, PhD; Anthony Palmieri, RPh, PharmD; and Steven M. Kymes, PhD
Darius N. Lakdawalla, PhD; Michael R. Eber, BSE; Felicia M. Forma, BSc; Jeffrey Sullivan, MS; Pierre-Carl Michaud, PhD; Lily A. Bradley, MBA; and Dana P. Goldman, PhD
Hospital systems across the country are increasingly vying to establish some of the first treatment centers to provide proton beam therapy, a high-tech radiation treatment for cancer.